# Reliant Holding, Ltd. – FDA Inspection, Feb 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/reliant-holding-ltd/150e5012-ca03-494f-ba72-76de4497e84f
Source feed: FDA_Inspections

> FDA inspection 1000724 of Reliant Holding, Ltd., February 02, 2017. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000724
- Company Name: Reliant Holding, Ltd.
- Inspection Date: 2017-02-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1290004 - 2025-10-29
- FDA Inspection 968748 - 2016-03-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/shawn-e-larson/a3515e47-60a3-48ff-b27c-f79bd03db12b)

Company: https://www.keypedia.com/companies/reliant-holding-ltd/14966b48-ea6c-415f-86f0-ac8d2585ef22

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c